Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9726 |
High Similarity |
NPD1934 |
Approved |
0.9527 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9267 |
High Similarity |
NPD2801 |
Approved |
0.9226 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9226 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9226 |
High Similarity |
NPD6166 |
Phase 2 |
0.9048 |
High Similarity |
NPD1511 |
Approved |
0.9028 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9028 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.902 |
High Similarity |
NPD3882 |
Suspended |
0.8994 |
High Similarity |
NPD7074 |
Phase 3 |
0.8966 |
High Similarity |
NPD1549 |
Phase 2 |
0.8954 |
High Similarity |
NPD3817 |
Phase 2 |
0.8931 |
High Similarity |
NPD7054 |
Approved |
0.8926 |
High Similarity |
NPD1512 |
Approved |
0.8896 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8875 |
High Similarity |
NPD7472 |
Approved |
0.8868 |
High Similarity |
NPD3818 |
Discontinued |
0.8859 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8846 |
High Similarity |
NPD5494 |
Approved |
0.8816 |
High Similarity |
NPD4380 |
Phase 2 |
0.8718 |
High Similarity |
NPD7075 |
Discontinued |
0.8718 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD7808 |
Phase 3 |
0.8704 |
High Similarity |
NPD6797 |
Phase 2 |
0.8699 |
High Similarity |
NPD2796 |
Approved |
0.865 |
High Similarity |
NPD7251 |
Discontinued |
0.8645 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.863 |
High Similarity |
NPD1510 |
Phase 2 |
0.8598 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.859 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6959 |
Discontinued |
0.8526 |
High Similarity |
NPD7819 |
Suspended |
0.85 |
High Similarity |
NPD6232 |
Discontinued |
0.8483 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8466 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8457 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8397 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8367 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8366 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8291 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8231 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8217 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD5402 |
Approved |
0.811 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8108 |
Intermediate Similarity |
NPD943 |
Approved |
0.8098 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8086 |
Intermediate Similarity |
NPD919 |
Approved |
0.8082 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8027 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8025 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8025 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7973 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7961 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7961 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7933 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7922 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7898 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7871 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7834 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7778 |
Intermediate Similarity |
NPD37 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7758 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7744 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7724 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7688 |
Intermediate Similarity |
NPD920 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7662 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7662 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD1653 |
Approved |
0.763 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7576 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7571 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7548 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7533 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5710 |
Approved |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7386 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7383 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7358 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7349 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7322 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7315 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7249 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7248 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7244 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7239 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7209 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6779 |
Approved |
0.72 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7174 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7167 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7161 |
Intermediate Similarity |
NPD411 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7125
|
Intermediate Similarity |
NPD7266 |
Discontinued |